Search

Author/Creator Busacca, Sara

1. Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. (June 2022)

Authors:
Fennell, Dean A.; Porter, Catharine; Lester, Jason; Danson, Sarah; Taylor, Paul; Sheaff, Michael; Rudd, Robin M; Gaba, Aarti; Busacca, Sara; Nixon, Lisette; Gardner, Georgina; Darlison, Liz; Poile, Charlotte; Richards, Cathy; Jordan, Peter-Wells; Griffiths, Gareth; Casbard, Angela
Journal:
EClinicalMedicine
Issue:
Volume 48(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed. Issue 8 (20th February 2007)

Authors:
Bertino, Pietro; Porta, Camillo; Barbone, Dario; Germano, Serena; Busacca, Sara; Pinato, Sabrina; Tassi, Giancarlo; Favoni, Roberto; Gaudino, Giovanni; Mutti, Luciano
Journal:
Thorax
Issue:
Volume 62:Issue 8(2007)
Page Start:
690
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search